Ruxolitinib: an oral Janus kinase 1 and Janus kinase 2 inhibitor in the management of myelofibrosis.
about
Experience with ruxolitinib in the treatment of polycythaemia vera.Profile of pomalidomide and its potential in the treatment of myelofibrosis.JAK/STAT regulation of Aspergillus fumigatus corneal infections and IL-6/23-stimulated neutrophil, IL-17, elastase, and MMP9 activity.Mutations and chromosomal rearrangements of JAK2: not only a myeloid issue.An update on allogeneic hematopoietic progenitor cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors.Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy.Ruxolitinib for myelofibrosis: from 'palliation' to prolongation of survival.Computational identification of potential multi-drug combinations for reduction of microglial inflammation in Alzheimer disease.Ruxolitinib found to cause eyelash growth: a case report.Tips on using ruxolitinib in everyday practice as therapy for myelofibrosis.Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis.
P2860
Q33605624-D055499C-72E3-4775-B8F2-D02D0BA37825Q35427915-746EBAED-565C-4E3A-BB83-094BE71D3DD7Q37098061-481211E9-37A9-4642-A07D-7092F13770FEQ38132817-E711842A-E791-495F-B1E0-7BA1723B0FCCQ38236642-CCE7EFAE-D6F9-4682-BC61-4A5300B587CEQ38489591-F542FD9A-BDA2-4EB2-978C-430C79A38498Q39883393-931E51E5-E2F0-4AFC-B679-54565208468AQ40813292-3358E5DF-B65B-4FE2-A439-DD949CA59581Q41003544-45A5137F-00EC-4B83-9A71-6164704A33C1Q41845692-2C438BD1-05A2-4C35-B6D2-E0646D26EBE5Q45957917-5F7122C7-D667-44CB-A075-5A4705138B03
P2860
Ruxolitinib: an oral Janus kinase 1 and Janus kinase 2 inhibitor in the management of myelofibrosis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Ruxolitinib: an oral Janus kin ...... e management of myelofibrosis.
@ast
Ruxolitinib: an oral Janus kin ...... e management of myelofibrosis.
@en
type
label
Ruxolitinib: an oral Janus kin ...... e management of myelofibrosis.
@ast
Ruxolitinib: an oral Janus kin ...... e management of myelofibrosis.
@en
prefLabel
Ruxolitinib: an oral Janus kin ...... e management of myelofibrosis.
@ast
Ruxolitinib: an oral Janus kin ...... e management of myelofibrosis.
@en
P2860
P356
P1476
Ruxolitinib: an oral Janus kin ...... e management of myelofibrosis.
@en
P2860
P304
P356
10.3810/PGM.2013.01.2628
P407
P577
2013-01-01T00:00:00Z